Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA is a highly conserved, ~120-nucleotide RNA that forms a critical part of the eukaryotic (and prokaryotic) large ribosomal subunit (60S in eukaryotes)[1][2]. It serves a structural and organizational role in the assembly and function of the ribosome, bridging ribosomal proteins and other rRNA to guide ribosomal biogenesis and ensure efficient protein synthesis[1][2][3]. The term "5S ribosomal RNA 4" likely refers to one member of a set of tandemly repeated 5S rRNA genes (with “4” indicating a specific copy or locus), which are common in higher eukaryotic genomes[1][2]. 5S rRNA is not a therapeutic target (such as a receptor, enzyme, or transporter), nor is it commonly associated as a direct biomarker or drug target, but its essential function means genetic or biogenetic disruptions can have profound effects on cell growth and protein production[1][2].
Not applicable (RNAs of this class themselves are not targets of therapeutic agents; their disruption by antibiotics such as in bacteria may involve interaction with associated ribosomal proteins or RNA regions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA 4 (5S rRNA 4).